Job title: CBO
Dr. Vafa joined TeneoBio as Chief Business Officer in February 2016. He has more than 15 years of global business and scientific experience in biotechnology and pharmaceutical drug discovery, asset evaluation, transactions and licensing. Prior to joining TeneoBio, Dr. Vafa was the Director of Strategy and Scientific Partnerships at Janssen Pharmaceutical Companies of Johnson and Johnson and the Biotechnology and Oncology Lead at the London Innovation Center of J&J. Dr. Vafa earned his doctorate at Georgetown University, his MBA from the Villanova University School of Business, and his B.S. from the University of California at Irvine. He completed his post-doctoral fellowships at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies in La Jolla, California.
Chair’s Closing Remarks & End of Virtual Conference 5:00 pm
day: Day Two
Discovering and Designing the Next Generation of T cell Engagers 1:15 pm
Approaches to increasing the therapeutic window of T cell engagers Combination therapies to improve efficacy Redirecting the immune system with the next generation of multi-specificsRead more
day: Day One